Electric Cardiometry-Guided Standard Versus Restricted Fluid Therapy In Robotic Prostaectomy

Recruiting N/A Interventional Study
Prostate Cancer Surgery Fluid Overload Lactate Blood Increase
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 80
Sex
Male
Study type
Interventional
Purpose
Supportive Care
Participants needed
90 (estimated)
Sponsor
Nazmy Edward Seif · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Fluid therapy during surgery is an important factor that is related to long term mortality and morbidity and it's directly related to tissue perfusion as well. The main target in any surgery is what is the optimum fluid therapy to maintain the tissue perfusion and the precise balance between hazardous effects of hypervolemia that may cause delayed wound healing due to surgical anastomosis disrupti…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male patient undergoing robotic assisted prostatectomy * ASA I-III Exclusion Criteria: * ASA score more than III * BMI more than 40 * Severe renal disease (GFR between 15 and 29) * Previous renal surgery. * Decompensated cardiac disease (NYHA class 3 or 4)
Contacts

Mohamed M Mohamed, M.Sc.

+20 111 8370641

mandamembo0@gmail.com

CONTACT

Nazmy S Mikhael, M.D.

+20122 7400808

drnazmyseif@kasralainy.edu.eg

CONTACT